[Ip-health] Shasun Signs Licence With MPP to Produce Low-Cost HIV Medicines
kmara at medicinespatentpool.org
Tue Mar 26 05:02:37 PDT 2013
The Medicines Patent Pool has signed a licence with Shasun Pharmaceuticals and Gilead Sciences that will allow Shasun to produce the active ingredients of 5 key HIV medicines licensed to the MPP by Gilead Sciences for sale in the 100-112 countries where the majority of people living with HIV reside.
Shasun is an India-based active pharmaceutical ingredient (API) manufacturer. Shasun is the sixth generic manufacturer to take a licence from the Medicines Patent Pool. MPP’s other licensees – Aurobindo, Emcure, Hetero, and Laurus Labs – are already producing HIV medicines for use in developing countries.
See the full announcement here:
Kaitlin Mara | Communications Manager | Medicines Patent Pool
direct: +41 22 791 6344 | mobile: +41 79 825 4786 | kmara at medicinespatentpool.org
Website<http://www.medicinespatentpool.org> | Newsletter<http://www.medicinespatentpool.org/news-room/newsletter/> | Twitter<http://twitter.com/MedsPatentPool> | Facebook<https://www.facebook.com/MedicinesPatentPool>
More information about the Ip-health